Boom-Boom Bridging Radiation Prior to Lisocabtagene Maraleucel Clinical Trial: Outcomes By Total Metabolic Tumor Volume

Puntos clave

• Total metabolic tumor volume significantly influences treatment outcomes, suggesting optimized therapy is needed.
• Participants with higher tumor volume show different responses, which may guide patient selection for clinical trials.
• Assessment involves metabolic imaging techniques to measure tumor metabolic activity pre-treatment and post-radiation.
• Findings highlight the importance of individualized radiation doses based on tumor volume to improve response rates.